Evidence map›Paper›PMID 40550847›Full record

ArticleOncogene2025

Vimentin intermediate filaments orchestrate DNA nonhomologous end joining repair and lipolysis after DNA damage.

Feifei Wang, Mengtao Rong, Liang Zhang, Abhishikt D Solomon, Wenli Gui, Juan Li, Renqing Wang, Jiajing Wu, Ling Wang, Xingyuan Yang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Targeting the Vim-PGIHuman mutation · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Feifei WangInstitute of Health Sciences and Technology, Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, Anhui, PR China. feifei.wang@ahu.edu.cn.ORCID http://orcid.org/0000-0003-1325-8177
Mengtao RongInstitute of Health Sciences and Technology, Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, Anhui, PR China.
Liang ZhangDepartment of Orthopedics, Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi, PR China.
Abhishikt D SolomonDepartment of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Wenli GuiInstitute of Health Sciences and Technology, Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, Anhui, PR China.
Juan LiInstitute of Health Sciences and Technology, Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, Anhui, PR China.
Renqing WangDepartment of Pathology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Jiajing WuInstitute of Health Sciences and Technology, Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, Anhui, PR China.
Ling WangDepartment of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Xingyuan YangInstitute of Health Sciences and Technology, Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, Anhui, PR China. xingyuan@ahu.edu.cn.
Aimin PengDepartment of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. penga@UNC.edu.ORCID http://orcid.org/0000-0002-2452-1949

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32400595
6 · The paper itself

Abstract

Vimentin is a major component of intermediate filaments (IFs) within the three cytoskeletal systems, alongside actin filaments and microtubules. Spanning from the plasma membrane to the nuclear lamina, vimentin IFs form a cage-like network surrounding the nucleus, and modulate cell mechanics, migration and signaling. In this study, we show that vimentin depletion leads to accumulation of endogenous DNA damage. Interestingly, vimentin is associated with Ku proteins that sense DNA double strand breaks (DSB) and mediate nonhomologous end joining (NHEJ) repair. Depletion of vimentin impairs NHEJ repair, in line with reduced recruitment of Ku proteins to DNA damage sites and deficient activation of DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Beyond its involvement in DSB repair, our research also uncovers the role of vimentin in modulating lipolysis following DNA damage. We show that DNA damage reduces lipid droplet contents via adipose triglyceride lipase (ATGL). Vimentin binds to and suppresses ATGL in lipolysis. Moreover, DNA-PKcs modulates ATGL and DNA damage-induced lipolysis via vimentin. Targeting vimentin leads to DNA damage hypersensitivity, suggesting its potential in cancer therapy. Taken together, our findings elucidate new roles of vimentin in orchestrating DNA repair and lipolysis, shedding light on the involvement of vimentin IF in cell homeostasis, cancer resistance, and metabolic regulation.

Indexed as

DNA DamageDNA End-Joining RepairIntermediate FilamentsLipolysisVimentinAcyltransferasesDNA-Activated Protein KinaseDNA Breaks, Double-StrandedHumansKu AutoantigenLipaseAcyltransferasesDNA-Activated Protein KinaseKu AutoantigenLipasePNPLA2 protein, humanVimentin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.